Evidence map›Paper›PMID 39822297›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Older US adults' experiences with and views about cognitive screening and blood biomarker testing for Alzheimer's disease.

Chelsea G Cox, Matthias Kirch, Dianne Singer, Erica Solway, Preeti N Malani, Jeffrey T Kullgren, J Scott Roberts

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Observational
  2. Perceptions of Alzheimer's Disease Among Cognitively Healthy, Community-Dwelling Older Adults: A Metaphor Study.Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2026
    Article
  3. Article
  4. Patient views on blood-based biomarker tests for Alzheimer's disease in primary care.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chelsea G CoxDepartment of Health Behavior and Health Equity University of Michigan School of Public Health Ann Arbor Michigan USA.ORCID https://orcid.org/0000-0002-5247-9119
Matthias KirchUniversity of Michigan Institute for Healthcare Policy and Innovation Ann Arbor Michigan USA.
Dianne SingerUniversity of Michigan Institute for Healthcare Policy and Innovation Ann Arbor Michigan USA.
Erica SolwayUniversity of Michigan Institute for Healthcare Policy and Innovation Ann Arbor Michigan USA.
Preeti N MalaniDepartment of Internal Medicine University of Michigan Medical School Ann Arbor Michigan USA.
Jeffrey T KullgrenUniversity of Michigan Institute for Healthcare Policy and Innovation Ann Arbor Michigan USA.
J Scott RobertsDepartment of Health Behavior and Health Equity University of Michigan School of Public Health Ann Arbor Michigan USA.

Funding

Research Education ComponentP30AG072931 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Henry L Paulson · 2021 to 2026
$26.5M
Interdisciplinary Research Training on Health and AgingT32AG027708 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Lindsay C Kobayashi, Briana Mezuk · 2008 to 2026
$2.7M
NIA NIH HHS P30 AG072931NIA NIH HHS T32 AG027708
6 · The paper itself

Abstract

introductionDementia is underdiagnosed in the United States. Understanding of older adults' experiences with screening is needed to optimize diagnosis.

methodsUS adults ages 65 to 80 (

resultsMost older adults were aware of screening (71%); 41% reported ever being screened. Older age, higher education, retirement, poorer health, and family history of dementia were associated with higher odds of screening; Hispanic and non-Hispanic Asian race/ethnicity were associated with lower odds ( DISCUSSION: Cognitive screening rates remain low. Older adults view screening and BBM as useful to inform health decisions but have concerns about potential harms. Highlights: Only one in five older US adults report having cognitive screening in the past year.Sociodemographic and health factors may influence whether older adults receive cognitive screening.Most older adults have positive views about cognitive screening and BBM testing.Many older adults would be concerned about distress or stigma if test result indicated dementia risk.

Indexed as

Alzheimer's diseasebiomarker testingblood‐based biomarkerscognitive screeningdementiaearly detection

Identifiers

PMID39822297
PMCPMC11736703

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.